Pharma Industry News Weekly Recap: September 15, 2023
// Biotech and Pharma Therapeutics AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology September [...]
// Biotech and Pharma Therapeutics AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology September [...]
// Biotech and Pharma Therapeutics Pfizer's Litfulo enters the scene in alopecia with adolescent nod to rival Lilly's [...]
// Biotech and Pharma Therapeutics Eli Lilly's Mounjaro is primed to overtake Novo Nordisk's popular diabetes and obesity [...]
// Biotech and Pharma Therapeutics Uber Health Launches Grocery & OTC Item Delivery to Patient Homes Nationwide June [...]
// Biotech and Pharma Therapeutics Lilly's Innovative Approach in the Pursuit of Pain Relief June 5, 2023 / [...]
// Biotech and Pharma Therapeutics Atea rejects takeover bid from Concentra May 30, 2023 / Atea / Concentra [...]
// Biotech and Pharma Therapeutics Bayer's blockbuster hopeful Nubeqa, AstraZeneca's Forxiga pick up nods from England's NICE May [...]
// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May [...]
// Biotech and Pharma Therapeutics Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal May [...]
// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA [...]